Journal of the American Medical Association – JAMA. Published online September 16, 2008 (free articles as follows):

• Association of Urinary Bisphenol A Concentration With Medical Disorders and Laboratory Abnormalities in Adults – “Using data representative of the adult US population, we found that higher urinary concentrations of BPA were associated with an increased prevalence of cardiovascular disease, diabetes, and liver-enzyme abnormalities. These findings add to the evidence suggesting adverse effects of low-dose BPA in animals. Independent replication and follow-up studies are needed to confirm these findings and to provide evidence on whether the associations are causal.”
• Bisphenol A and Risk of Metabolic Disorders: “Based on this background information, the study by Lang et al, while preliminary with regard to these diseases in humans, should spur US regulatory agencies to follow the recent action taken by Canadian regulatory agencies, which have declared BPA a “toxic chemical” requiring aggressive action to limit human and environmental exposures. Alternatively, Congressional action could follow the precedent set with the recent passage of federal legislation designed to limit exposures to another family of compounds, phthalates, also used in plastic. Like BPA, phthalates are detectable in virtually everyone in the United States. This bill moves US policy closer to the European model, in which industry must provide data on the safety of a chemical before it can be used in products.”
• Related postings on Bisphenol A